X

Health Care

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with…

CVS Health raises guidance for FY25 revenue and adjusted earnings

Healthcare services company CVS Health (NYSE: CVS) has updated its 2025 full-year financial guidance and issued forecasts for fiscal 2026.…

IPO News: What to look for when Lumexa Imaging goes public

IPO activity rebounded in the second half of the year, with the technology and healthcare sectors maintaining their dominance in…

Earnings Summary: CooperCompanies reports higher Q4 revenue, adj. profit

CooperCompanies (NYSE: COO) has reported an increase in revenues and adjusted earnings for the fourth quarter of fiscal 2025. The…

MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates

Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings for the second quarter of…

Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO

CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on…

Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance

Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter of fiscal 2025, and updated…

Earnings Summary: Humana Q3 2025 profit drops despite higher revenues

Humana Inc. (NYSE: HUM), a leading health and well-being company, on Wednesday reported a decline in adjusted earnings for the…

Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report

Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third…

PFE Earnings: All you need to know about Pfizer’s Q3 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its third quarter 2025 earnings results today. Revenues were $16.7 billion, down 6% on a…

Earnings Summary: Highlights of IDEXX’s Q3 2025 report

Medical device company IDEXX Laboratories, Inc. (NASDAQ: IDXX) on Monday reported higher revenues and earnings for the third quarter of…

ABBV Earnings: A snapshot of AbbVie’s Q3 2025 report

Pharmaceuticals company AbbVie, Inc. (NYSE: ABBV) on Friday reported a decline in earnings for the third quarter of fiscal 2025,…

BIIB Earnings: A snapshot of Biogen’s Q3 2025 results

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported an increase in adjusted profit for the third quarter of 2025 when its…

Earnings Summary: Cardinal Health Q1 2026 revenue jumps 22%; raises guidance

Pharmaceuticals distributor Cardinal Health (NYSE: CAH) reported a sharp increase in revenue and adjusted earnings for the first quarter of…

Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers

Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings results today. Revenues increased 3% year-over-year to $12.2 billion.…

Eli Lilly (LLY) Earnings: 3Q25 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported its third quarter 2025 earnings results today. Worldwide revenue was $17.60 billion, up…

Key highlights from Merck’s (MRK) Q3 2025 earnings results

Merck & Co., Inc. (NYSE: MRK) reported its third quarter 2025 earnings results today. Total worldwide sales of $17.3 billion…

UnitedHealth Group’s Q3 2025 earnings fall despite double-digit revenue growth

Healthcare behemoth UnitedHealth Group (NYSE: UNH) announced results for the third quarter of fiscal 2025, reporting an increase in revenues…

Earnings Summary: HCA Healthcare Q3 adj. profit jumps on strong revenue growth

Health services behemoth HCA Healthcare, Inc. (NYSE: HCA) has reported a sharp increase in adjusted earnings for the third quarter…

Earnings Summary: A snapshot of Revvity’s (RVTY) Q3 2025 report

Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, reported a decline in adjusted earnings for the…

Earnings Summary: Highlights of Boston Scientific’s Q3 2025 results

Medical device maker Boston Scientific Corporation (NYSE: BSX) on Wednesday reported financial results for the third quarter of 2025. The company…